Anti-Oxidant, Anti-Inflammatory and Anti-Allergic Activities of Luteolin

 

 Permissions and Reprints

Abstract

Luteolin is a flavone which occurs in medicinal plants as well as in some vegetables and spices. It is a natural anti-oxidant with less pro-oxidant potential than the flavonol quercetin, the best studied flavonoid, but apparently with a better safety profile. It displays excellent radical scavenging and cytoprotective properties, especially when tested in complex biological systems where it can interact with other anti-oxidants like vitamins. Luteolin displays specific anti-inflammatory effects at micromolar concentrations which are only partly explained by its anti-oxidant capacities. The anti-inflammatory activity includes activation of anti-oxidative enzymes, suppression of the NFκB pathway and inhibition of pro-inflammatory substances. In vivo, luteolin reduced increased vascular permeability and was effective in animal models of inflammation after parenteral and oral application. Although luteolin is only a minor component in our nutrition (less than 1 mg/day) epidemiological studies indicate that it has the potential to protect from diseases associated with inflammatory processes such as cardiovascular disease. Luteolin often occurs in the form of glycosides in plants, but these are cleaved and the aglycones are conjugated and metabolized after nutritional uptake which has to be considered when evaluating in vitro studies. Some data for oral and topical bioavailability exist, but more quantitative research in this field is needed to evaluate the physiological and therapeutical potential of luteolin.

Abbreviations

Akt:serine/threonin protein kinase B

COX-2:cyclooxygenase-2

CVD:cardiovascular disease

DPPH:2,2-diphenyl-1-picrylhydrazyl

EAE:experimental autoimmune encephalomyelitis

EGCG:epigallocatechin 3-gallate

fMLP:fMetLeuPhe, formyl peptide

GSH:glutathione

IFN-γ:interferon γ

IκB:Inhibitor of kappa B

IL:interleukin

iNOS:inducible nitric oxygen synthase

IP-10:inducible nitric oxygen synthase

IRF:interferon regulatory factor

LPS:lipopolysaccharide

LysoPAF AcTF:1-lysophospholipide acetyltransferase

MAPK:mitogen-activated protein kinase

M-CSF:macrophage colony-stimulating factor

NFκB:nuclear factor kappa B

8-OHdG:8-hydroxy-2′-deoxyguanosine

PGE₂:prostaglandin E₂

PMA:phorbol myristate acetate

ROS:reactive oxygen species

TEAC:trolox equivalent anti-oxidant capacity

TNF-α:tumor necrosis factor-α

References

• 1 USDA databank for the flavonoid content of selected foods, 2nd release 2007. Available at http://www.ars.usda.gov/nutrientdata Accessed June 13, 2008
  Google Scholar
• 2 Schempp C M, Wähling A, Lange E. Method for the production of flavonoid-containing compositions and use thereof. European patent EP 1 648 566 B1 2008
  Google Scholar
• 3 Heilmann J, Merfort I. Aktueller Kenntnisstand zum Metabolismus von Flavonoiden. II. Resorption und Metabolismus von Flavonen, Flavanonen, Flavanen, Procyanidinen und Isoflavonoiden.  Pharm Unserer Zeit. 1998;  27 173-83
  CrossrefPubMedGoogle Scholar
• 4 Huang D, Ou B, Prior R L. The chemistry behind antioxidant capacity assays.  J Agric Food Chem. 2005;  53 1841-56
  CrossrefPubMedGoogle Scholar
• 5 Apak R, Güçlü K, Demirata B, Ozyürek M, Celik S E, Bektaşoglu B. et al . Comparative evaluation of various total antioxidant capacity assays applied to phenolic compounds with the CUPRAC assay.  Molecules. 2007;  12 1496-547
  CrossrefPubMedGoogle Scholar
• 6 Havsteen B H. The biochemistry and medical significance of the flavonoids.  Pharmacol Ther. 2002;  96 67-202
  CrossrefPubMedGoogle Scholar
• 7 Heim K E, Tagliaferro A R, Bobilya D J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships.  J Nutr Biochem. 2002;  13 572-84
  CrossrefPubMedGoogle Scholar
• 8 Belyakov V A, Roginsky V A, Bors W. Rate constant for the reaction of peroxyl free radical with flavonoids and related compounds as determined by the kinetic chemoluminescence method. J Chem Soc [Perkin 2] 1995: 2319-36
  Google Scholar
• 9 Jovanovic S V, Steenken S, Hara Y, Simic M G. Reduction potential of flavonoid and model phenoxyl radicals. Which ring in flavonoids is responsible for antioxidant activity?. J Chem Soc [Perkin 2] 1996: 2497-504
  Google Scholar
• 10 Rice-Evans C A, Miller N J, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids.  Free Radic Biol Med. 1996;  20 933-1056
  CrossrefPubMedGoogle Scholar
• 11 Brown J E, Khodr H, Hider R C, Rice-Evans C A. Structural dependence of flavonoid interactions with Cu²⁺ ions: implications for their antioxidant properties.  Biochem J. 1998;  330 1173-8
  PubMedGoogle Scholar
• 12 Pietta P G. Flavonoids as antioxidants.  J Nat Prod. 2000;  63 1035-42
  CrossrefPubMedGoogle Scholar
• 13 Romanová D, Vachálková A, Cipák L, Ovesná Z, Rauko P. Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method.  Neoplasma. 2001;  48 104-7
  PubMedGoogle Scholar
• 14 Galvez J, de la Cruz J P, Zarzuelo A, Sanchez de la Cuesta F. Flavonoid inhibition of enzymic and nonenzymic lipid peroxidation in rat liver differs from its influence on the glutathione-related enzymes.  Pharmacology. 1995;  51 27-33
  PubMedGoogle Scholar
• 15 Shimoi K, Masuda S, Shen B, Furugori M, Kinae N. Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice.  Carcinogenesis. 1994;  15 2669-72
  CrossrefPubMedGoogle Scholar
• 16 Gal S, Lichtenberg D, Bor A, Pinchuk I. Copper-induced peroxidation of phosphatidylserine-containing liposomes is inhibited by nanomolar concentrations of specific antioxidants.  Chem Phys Lipids. 2007;  150 86-203
  PubMedGoogle Scholar
• 17 Hirano R, Sasamoto W, Matsumoto A, Itakura H, Igarashi O, Kondo K. Antioxidant ability of various flavonoids against DPPH radicals and LDL oxidation.  J Nutr Sci Vitaminol (Tokyo). 2001;  47 357-62
  CrossrefPubMedGoogle Scholar
• 18 Horváthová K, Novotný L, Vachálková A. The free radical scavenging activity of four flavonoids determined by the comet assay.  Neoplasma. 2003;  50 291-5
  PubMedGoogle Scholar
• 19 Horváthová K, Novotný L, Tóthová D, Vachálková A. Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H₂O₂-treated human ML cells K562.  Neoplasma. 2004;  51 395-9
  PubMedGoogle Scholar
• 20 Horváthová K, Chalupa L, Sebova D, Tóthová D, Vachálková A. Protective effect of quercetin and luteolin in human melanoma HMB-2 cells.  Mutat Res. 2005;  565 105-12
  PubMedGoogle Scholar
• 21 Noroozi M, Angerson W J, Lean M E. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes.  Am J Clin Nutr. 1998;  67 1210-8
  CrossrefPubMedGoogle Scholar
• 22 Steffan B. Inhaltsstoffe aus Pflanzen der indonesischen Volksmedizin (Jamu): Isolierung, Identifizierung, und Charakterisierung der antioxidativen Eigenschaften [dissertation]. Düsseldorf; Heinrich Heine Universität 2005
  Google Scholar
• 23 Pérez-García F, Adzet T, Canigueral S. Activity of artichoke leaf extract on reactive oxygen species in human leukocytes.  Free Radic Res. 2000;  33 661-5
  CrossrefPubMedGoogle Scholar
• 24 Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification.  Toxicol Pathol. 2002;  30 620-50
  CrossrefPubMedGoogle Scholar
• 25 Gebhardt R, Rexhepaj R, Fausel M. Vergleich der antioxidativen und hepatoprotektiven Wirkung von Flavonoiden aus Blattextrakten der Artischocke (Cynara scolymus) an Hepatocytenkulturen unter Einwirkung toxischer Hydroperoxide. Phytopharmakaforschung 2000, Tagung der Ges Phytotherapie und Ges Arzneipflanzenforschung Bonn; 1998
  Google Scholar
• 26 Wolfe K L, Liu R H. Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements.  J Agric Food Chem. 2007;  55 8896-907
  CrossrefPubMedGoogle Scholar
• 27 Harris G K, Qian Y, Leonard S S, Sbarra D C, Shi X. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells.  J Nutr. 2006;  136 1517-21
  PubMedGoogle Scholar
• 28 Wang X G, Chen G Y, Chen M P. Effect of luteolin on COX-2 and mPGES-1 expression in LPS-induced RAW264.7 cells.  Zhong yao cai - J Chin Med Mater. 2008;  30 1263-6
  PubMedGoogle Scholar
• 29 Psotová J, Chlopcíková S, Miketová P, Hrbác J, Simánek V. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempferol, luteolin and quercetin.  Phytother Res. 2004;  18 516-21
  CrossrefPubMedGoogle Scholar
• 30 Kanazawa K, Uehara M, Yanagitani H, Hashimoto T. Bioavailable flavonoids to suppress the formation of 8-OHdG in HepG2 cells.  Arch Biochem Biophys. 2006;  455 197-203
  CrossrefPubMedGoogle Scholar
• 31 Qiusheng Z, Yuntao Z, Rongliang Z, Dean G, Changling L. Effects of verbascoside and luteolin on oxidative damage in brain of heroin treated mice.  Pharmazie. 2005;  60 539-43
  PubMedGoogle Scholar
• 32 Ruiz P A, Haller D. Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells.  J Nutr. 2006;  136 664-71
  PubMedGoogle Scholar
• 33 Kim J S, Lee H J, Lee M H, Kim J, Jin C, Ryu J H. Luteolin inhibits LPS-stimulated inducible nitric oxide synthase expression in BV-2 microglial cells.  Planta Med. 2006;  72 65-8
  Article in Thieme ConnectPubMedGoogle Scholar
• 34 Comalada M, Ballester I, Bailón E, Sierra S, Xaus J, Gálvez J. et al . Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship.  Biochem Pharmacol. 2006;  72 010-21
  PubMedGoogle Scholar
• 35 Kim E K, Kwon K B, Song M Y, Han M J, Lee J H, Lee Y R. Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation.  Pancreas. 2007;  35 1-9
  CrossrefPubMedGoogle Scholar
• 36 Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages.  J Pharmacol Exp Ther. 2001;  296 181-7
  PubMedGoogle Scholar
• 37 Hirano T, Higa S, Arimitsu J, Naka T, Shima Y, Ohshima S. et al . Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils.  Arch Allergy Immunol. 2004;  134 135-40
  CrossrefPubMedGoogle Scholar
• 38 Kawai M, Hirano T, Higa S, Arimitsu J, Maruta M, Kuwahara Y. et al . Flavonoids and related compounds as anti-allergic substances.  Allergol Int. 2007;  56 113-23
  CrossrefPubMedGoogle Scholar
• 39 Park K Y, Lee S H, Min B K, Lee K S, Choi J S, Chung S R. et al . Inhibitory effect of luteolin 4′-O-glucoside from Kummerowia striata and other flavonoids on interleukin-5 bioactivity.  Planta Med. 1999;  65 457-9
  Article in Thieme ConnectPubMedGoogle Scholar
• 40 Hirano T, Arimitsu J, Higa S, Naka T, Ogata A, Shima Y. et al . Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils.  Int Arch Allergy Immunol. 2006;  140 150-6
  CrossrefPubMedGoogle Scholar
• 41 Cheong H, Ryu S Y, Oak M H, Cheon S H, Yoo G S, Kim K M. Studies of structure activity relationship of flavonoids for the anti-allergic actions.  Arch Pharm Res. 1998;  21 78-80
  PubMedGoogle Scholar
• 42 Hougee S, Sanders A, Faber J, Graus Y M, van den Berg W B, Garssen J. et al . Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages.  Biochem Pharmacol. 2005;  69 241-8
  CrossrefPubMedGoogle Scholar
• 43 Kim H K, Cheon B S, Kim Y H, Kim S Y, Kim H P. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships.  Biochem Pharmacol. 1999;  58 759-65
  CrossrefPubMedGoogle Scholar
• 44 Verbeek R, Plomp A C, van Tol E A, van Noort J M. The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells.  Biochem Pharmacol. 2004;  68 621-9
  CrossrefPubMedGoogle Scholar
• 45 Verbeek R, van Tol E A, van Noort J M. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice.  Biochem Pharmacol. 2005;  70 220-8
  CrossrefPubMedGoogle Scholar
• 46 Kuppusamy U R, Khoo H E, Das N P. Structure-activity studies of flavonoids as inhibitors of hyaluronidase.  Biochem Pharmacol. 1990;  40 397-401
  CrossrefPubMedGoogle Scholar
• 47 Hertel W, Peschel G, Ozegowski J H, Müller P J. Inhibitory effects of triterpenes and flavonoids on the enzymatic activity of hyaluronic acid-splitting enzymes.  Arch Pharm (Weinheim). 2006;  339 313-8
  CrossrefPubMedGoogle Scholar
• 48 Choi E M. Modulatory effects of luteolin on osteoblastic function and inflammatory mediators in osteoblastic MC3T3-E1 cells.  Cell Biol Int. 2007;  31 870-7
  CrossrefPubMedGoogle Scholar
• 49 Yanoshita R, Chang H W, Son K H, Kudo I, Samejima Y. Inhibition of lysoPAF acetyltransferase activity by flavonoids.  Inflamm Res. 1996;  45 546-9
  CrossrefPubMedGoogle Scholar
• 50 Baolin L, Weiwei W, Ning T. Topical application of luteolin inhibits scratching behavior associated with allergic cutaneous reaction in mice.  Planta Med. 2005;  71 424-8
  Article in Thieme ConnectPubMedGoogle Scholar
• 51 Kimata M, Inagaki N, Nagai H. Effects of luteolin and other flavonoids on IgE-mediated allergic reactions.  Planta Med. 2000;  66 25-9
  Article in Thieme ConnectPubMedGoogle Scholar
• 52 Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells.  Clin Exp Allergy. 2000;  30 501-8
  CrossrefPubMedGoogle Scholar
• 53 Ueda H, Yamazaki C, Yamazaki M. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. .  Biol Pharm Bull. 2002;  25 1197-202
  CrossrefPubMedGoogle Scholar
• 54 Hendriks J J, Alblas J, van der Pol S M, van Tol E A, Dijkstra C D, de Vries H E. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.  J Exp Med. 2004;  200 1667-72
  CrossrefPubMedGoogle Scholar
• 55 Kotanidou A, Xagorari A, Bagli E, Kitsanta P, Fotsis T, Papapetropoulos A. et al . Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice.  Am J Respir Crit Care Med. 2002;  165 818-23
  PubMedGoogle Scholar
• 56 Kumazawa Y, Kawaguchi K, Takimoto H. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha.  Curr Pharm Des. 2006;  12 4271-9
  CrossrefPubMedGoogle Scholar
• 57 Ziyan L, Yongmei Z, Nan Z, Ning T, Baolin L. Evaluation of the anti-inflammatory activity of luteolin in experimental animal models.  Planta Med. 2007;  73 221-6
  Article in Thieme ConnectPubMedGoogle Scholar
• 58 Zhou P, Li L P, Luo S Q, Jiang H D, Zeng S. Intestinal absorption of luteolin from peanut hull extract is more efficient than that from individual pure luteolin.  J Agric Food Chem. 2008;  56 296-300
  CrossrefPubMedGoogle Scholar
• 59 Wittemer S M, Ploch M, Windeck T, Müller S C, Drewelow B, Derendorf H. et al . Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans.  Phytomedicine. 2005;  12 28-38
  CrossrefPubMedGoogle Scholar
• 60 Brown J E, Rice-Evans C A. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro. .  Free Radic Res. 1998;  29 247-55
  CrossrefPubMedGoogle Scholar
• 61 Boersma M G, van der Woude H, Bogaards J, Boeren S, Vervoort J, Cnubben N H. et al . Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.  Chem Res Toxicol. 2002;  15 662-70
  CrossrefPubMedGoogle Scholar
• 62 Shimoi K, Nakayama T. Glucuronidase deconjugation in inflammation.  Methods Enzymol. 2005;  400 263-72
  PubMedGoogle Scholar
• 63 Merfort I, Heilmann J, Hagedorn-Leweke U, Lippold B C. In vivo skin penetration studies on chamomile flavones.  Pharmazie. 1994;  49 509-11
  PubMedGoogle Scholar
• 64 Chavant L, Combie H, Crs J. Memorandum: new dietary ingredients.  Plant Med Phytother. 1975;  9 267-72
  PubMedGoogle Scholar
• 65 ai L M, Cheng H, Li W P, Liu S Q, Chen M X, Xu S Y. Memorandum: new dietary ingredients.  Acta Anhui Med Univ. 1985;  20 1-3
  PubMedGoogle Scholar
• 66 Mittra B, Saha A, Chowdhury A R, Pal C, Mandal S, Mukhopadhyay S. et al . Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.  Mol Med. 2000;  6 527-41
  PubMedGoogle Scholar
• 67 Czeczot H, Tudek B, Kusztelak J, Szymczyk T, Dobrowolska B, Glinkowska G. et al . Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs.  Mutat Res. 1990;  240 209-16
  CrossrefPubMedGoogle Scholar
• 68 Choi J S, Park K Y, Moon S H, Rhee S H, Young H S. Antimutagenic effect of plant flavonoids in the Salmonella assay system.  Arch Pharm Res. 1994;  17 71-5
  CrossrefPubMedGoogle Scholar
• 69 Kawanishi S, Oikawa S, Murata M. Evaluation for safety of antioxidant chemopreventive agents.  Antioxid Redox Signal. 2005;  7 1728-39
  CrossrefPubMedGoogle Scholar
• 70 Middleton E J r, Kandaswami C, Theoharides T C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.  Pharmacol Rev. 2000;  52 673-751
  PubMedGoogle Scholar
• 71 Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study.  BMJ. 1996;  312 478-81
  PubMedGoogle Scholar
• 72 Knekt P, Isotupa S, Rissanen H, Heliövaara M, Järvinen R, Häkkinen S. et al . Quercetin intake and the incidence of cerebrovascular disease.  Eur J Clin Nutr. 2000;  54 415-7
  CrossrefPubMedGoogle Scholar
• 73 Marniemi J, Alanen E, Impivaara O, Seppänen R, Hakala P, Rajala T. et al . Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects.  Nutr Metab Cardiovasc Dis. 2005;  15 188-97
  CrossrefPubMedGoogle Scholar
• 74 Mink P J, Scrafford C G, Barraj L M, Harnack L, Hong C P, Nettleton J A. et al . Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women.  Am J Clin Nutr. 2007;  85 895-909
  PubMedGoogle Scholar
• 75 Yochum L, Kushi L H, Meyer K, Folsom A R. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women.  Am J Epidemiol. 1999;  149 943-9
  PubMedGoogle Scholar
• 76 Sesso H D, Gaziano J M, Liu S, Buring J E. Flavonoid intake and the risk of cardiovascular disease in women.  Am J Clin Nutr. 2003;  77 1400-8
  PubMedGoogle Scholar
• 77 Tavani A, Spertini L, Bosetti C, Parpinel M, Gnagnarella P, Bravi F. et al . Intake of specific flavonoids and risk of acute myocardial infarction in Italy.  Public Health Nutr. 2006;  9 369-74
  CrossrefPubMedGoogle Scholar
• 78 Quintiery L, Palatini P, Nassi A, Ruzza P, Floreani M. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP 3A5 enzymes.  Biochem Pharmacol. 2008;  75 1426-37
  CrossrefPubMedGoogle Scholar
• 79 Wang X, Wang Q, Morris M E. Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters.  AAPS J. 2008;  10 47-55
  CrossrefPubMedGoogle Scholar
• 80 Ahlenstiel T, Burkhardt G, Köhler H, Kuhlmann M K. Improved cold preservation of kidney tubular cells by means of adding bioflavonoids to organ preservation solutions.  Transplantation. 2006;  81 231-9
  CrossrefPubMedGoogle Scholar
• 81 Chen C Y, Peng W H, Tsai K D, Hsu S L. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages.  Life Sci. 2007;  81 1602-14
  CrossrefPubMedGoogle Scholar
• 82 Gutiérrez-Venegas G, Kawasaki-Cárdenas P, Arroyo-Cruz S R, Maldonado-Frías S. Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts.  Eur J Pharmacol. 2006;  541 95-105      
  CrossrefPubMedGoogle Scholar
• 83 Hirano T, Higa S, Arimitsu J, Naka T, Ogata A, Shima Y. et al . Luteolin, a flavonoid, inhibits AP-1 activation by basophils.  Biochem Biophys Res Commun. 2006;  340 1-7
  CrossrefPubMedGoogle Scholar
• 84 Hu C, Kitts D D. Luteolin and luteolin 7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells.  Mol Cell Biochem. 2004;  265 107-13
  CrossrefPubMedGoogle Scholar
• 85 Kim S H, Shin K J, Kim D, Kim Y H, Han M S, Lee T G. et al . Luteolin inhibits the nuclear factor-kappa B transcriptional activity in Rat-1 fibroblasts.  Biochem Pharmacol. 2003;  66 955-63
  CrossrefPubMedGoogle Scholar
• 86 Lu H W, Sugahara K, Sagara Y, Masuoka N, Asaka Y, Manabe M. et al . Effect of three flavonoids, 5,7,3′,4′-tetrahydroxy-3-methoxy flavone, luteolin, and quercetin, on the stimulus-induced superoxide generation and tyrosyl phosphorylation of proteins in human neutrophil.  Arch Biochem Biophys. 2001;  393 73-7
  CrossrefPubMedGoogle Scholar
• 87 Odontuya G, Hoult J R, Houghton P J. Structure-activity relationship for anti-inflammatory effect of luteolin and its derived glycosides.  Phytother Res. 2005;  19 782-6
  CrossrefPubMedGoogle Scholar
• 88 Park B Y, Min B S, Oh S R, Kim J H, Bae K H, Lee H K. Isolation of flavonoids, a biscoumarin and an amide from the flower buds of Daphne genkwa and the evaluation of their anti-complement activity.  Phytother Res. 2006;  20 610-3
  CrossrefPubMedGoogle Scholar
• 89 Pieroni A, Heimler D, Pieters L, van Poel B, Vlietinck A J. In vitro anti-complementary activity of flavonoids from olive (Olea europaea L.) leaves.  Pharmazie. 1996;  51 765-8
  PubMedGoogle Scholar
• 90 Pieroni A, Pachaly P, Huang Y, Van Poel B, Vlietinck A J. Studies on anti-complementary activity of extracts and isolated flavones from Ligustrum vulgare and Phillyrea latifolia leaves (Oleaceae).  J Ethnopharmacol. 2000;  70 213-7
  CrossrefPubMedGoogle Scholar
• 91 Sharma V, Mishra M, Ghosh S, Tewari R, Basu A, Seth P. et al . Modulation of interleukin-1 beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection.  Brain Res Bull. 2007;  73 55-63
  CrossrefPubMedGoogle Scholar
• 92 Theoharides T C, Kempuraj D, Iliopoulou B P. Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis.  Adv Exp Med Biol. 2007;  601 423-30
  PubMedGoogle Scholar
• 93 Ueda H, Yamazaki C, Yamazaki M. A hydroxyl group of flavonoids affects oral anti-inflammatory activity and inhibition of systemic tumor necrosis factor-alpha production.  Biosci Biotechnol Biochem. 2004;  68 119-25
  CrossrefPubMedGoogle Scholar

Prof. Dr. med. Christoph M. Schempp

Competence Center Skintegral®

Department of Dermatology

University Medical Center Freiburg

Hauptstr. 7

79102 Freiburg

Germany

Phone: +49-761-270-6701

Fax: +49-761-270-6829

Email: christoph.schempp@uniklinik-freiburg.de